Verweise von und zu Nivolumab
Zurück zum ArtikelVerweise von anderen Artikeln
- Drug-induced bullous pemphigoid
- Cemiplimab
- Chronic lymphocytic thyroiditis
- Immune checkpoint inhibitors
- Immune related adverse events
- Ipilimumab
- Lag3
- Lichen planus pemphigoides
- Merkel cell carcinoma
- Monoclonal antibodies
- Pd-1 antibody
- Immune-related adverse events
- Pembrolizumab
- Decorative tattoo
- TIGIT
- IgA vascultis (Henoch-Schoenlein purpura)
Verweise zu anderen Artikeln
- Drug-induced bullous pemphigoid
- Cemiplimab
- Ipilimumab
- Lichen planus pemphigoides
- Pd-1 antibody
- Pembrolizumab